EHRA compiles a study to gain a better understanding of the use of new psychoactive substances (NPS) throughout Lithuania.

EMCDDA provides an assessment of how the pandemic has impacted sectors vulnerable to illicit drug markets.

The Center on Drug Policy Evaluation outlines drug policy reform and harm reduction priorities they believe the Biden administration should immediately act upon.

Hill, Fehér, and Bridge offer practical ways for practitioners and non-diplomats to engage in international drug policy debates.

INPUD's latest global AIDS strategy sets to equip health services with the necessary resources in order to maximize care for those with HIV.

GNP+ prepares a guide for supporting HIV/AIDS related causes and how to get involved across multiple networks.

SDF calls for a revision of the country's drug strategy with a greater focus on harm reduction and access to health services.

MENAHRA shines a light on the unsafety and limits in access to support facing people who use drugs in the region.

FEDITO BLX and IDPC make recommendations for Belgium's UPR, focusing on adopting a public health approach, decriminalising people who use drugs and providing a clear legal framework for drug consumption rooms.

TNI explains how reducing barriers for small farmers while raising them for large companies can help to steer legal cannabis markets in a more sustainable and equitable direction.

Frontline AIDS explains the need to shift focus from criminalising drugs to properly equipping health services and educational initiatives in order to address drug-related harms.

INPUD interrogates 'progress' toward decriminalisation, pointing to gaps and pending challenges, including in relation to enduring stigmatisation and prohibition.

IDPC provides a critique of the UNODC Strategy 2021-2025 with a focus on two critical issues: the exclusion of civil society and communities from the development and approval of the document; and the departure from the policy priorities established in the 2018 UN system Common Position on drugs.

IDPC takes stock of progress made on the implementation of the recommendations included in the UNGASS Outcome Document, focusing on six critical areas: public health, development, human rights, civil society engagement, UN agency collaboration and cooperation, and drug policy evaluation.

ITPC and Dristi Nepal offer insights into the challenges posed by the COVID-19 pandemic on populations impacted by HIV, and responses by civil society and community networks.

FCAA highlights how marginalised communities in the US and globally have been impacted by COVID-19 and how their needs have changed over the past year.

EHRA assesses harm reduction and law enforcement responses to new psychoactive substances in Estonia.

INHSU outlines challenges and opportunities in harm reduction responses during the COVID-19 pandemic.

IDPC and TNI provide an overview of the evolution of the UN-agreed language on key drug policy issues for the last three decades.

Despite a historic fall in the number of people executed for drug offences worldwide, the amount of people sentenced to death has worryingly increased.